Skip to Content
Merck

Optogenetic regulation of endogenous proteins.

Nature communications (2020-02-01)
Taras A Redchuk, Maksim M Karasev, Polina V Verkhusha, Sara K Donnelly, Maren Hülsemann, Jori Virtanen, Henna M Moore, Maria K Vartiainen, Louis Hodgson, Vladislav V Verkhusha
ABSTRACT

Techniques of protein regulation, such as conditional gene expression, RNA interference, knock-in and knock-out, lack sufficient spatiotemporal accuracy, while optogenetic tools suffer from non-physiological response due to overexpression artifacts. Here we present a near-infrared light-activatable optogenetic system, which combines the specificity and orthogonality of intrabodies with the spatiotemporal precision of optogenetics. We engineer optically-controlled intrabodies to regulate genomically expressed protein targets and validate the possibility to further multiplex protein regulation via dual-wavelength optogenetic control. We apply this system to regulate cytoskeletal and enzymatic functions of two non-tagged endogenous proteins, actin and RAS GTPase, involved in complex functional networks sensitive to perturbations. The optogenetically-enhanced intrabodies allow fast and reversible regulation of both proteins, as well as simultaneous monitoring of RAS signaling with visible-light biosensors, enabling all-optical approach. Growing number of intrabodies should make their incorporation into optogenetic tools the versatile technology to regulate endogenous targets.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Pan-Ras Antibody, clone RAS 10, clone RAS 10, from mouse